Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Clin Cardiol ; 16(5): 429-34, 1993 May.
Article in English | MEDLINE | ID: mdl-8504578

ABSTRACT

Magnesium has previously been used in the treatment of various arrhythmias, but few randomized and prospective studies are available. In a single-blind study, the efficacy and safety of intravenous magnesium sulfate (bolus doses of 5 + 5 mmol followed by infusion of 0.04 mmol/min) versus verapamil (5 + 5 mg followed by 0.1 mg/min) was evaluated in 57 patients with supraventricular arrhythmias (supraventricular tachycardia, atrial fibrillation, and atrial flutter) of recent onset (less than 1 week). Fifteen (58%) of the patients receiving magnesium (n = 26) converted to sinus rhythm within 4 h, and 16 (62%) within 24 h. Verapamil caused a lower ventricular rate, but only six (19%) of the patients (n = 31) converted to sinus rhythm within 4 h (p < 0.01) and 16 (52%) within 24 h (NS). No side effects were observed during magnesium infusion, whereas six patients receiving verapamil had to be withdrawn from further study medication due to symptomatic side effects (hypotension in three, cardiac failure in three). Magnesium appears to be an effective and safe drug for the treatment of supraventricular arrhythmias. The overall efficacy for conversion to sinus rhythm is at least as effective as with verapamil, and its action is more rapid.


Subject(s)
Arrhythmias, Cardiac/drug therapy , Magnesium/therapeutic use , Verapamil/therapeutic use , Atrial Fibrillation/drug therapy , Atrial Flutter/drug therapy , Female , Heart Rate/drug effects , Humans , Infusions, Intravenous , Injections, Intravenous , Magnesium/administration & dosage , Magnesium/blood , Male , Middle Aged , Remission Induction , Single-Blind Method , Tachycardia, Paroxysmal/drug therapy , Tachycardia, Supraventricular/drug therapy , Time Factors , Verapamil/administration & dosage , Verapamil/adverse effects
2.
Tidsskr Nor Laegeforen ; 110(20): 2629-33, 1990 Aug 30.
Article in Norwegian | MEDLINE | ID: mdl-2219027

ABSTRACT

We describe the symptomatology of different disease entities caused by group A beta-hemolytic streptococci (Streptococcus pyogenes, GAS). The case histories of four patients, two of whom died, emphasize the severity of certain clinical manifestations of GAS-infections. A 34 year-old woman was admitted to hospital four days after start of the symptoms. She presented a clinical picture very similar to that observed in fulminant meningococcal septicaemia; i.e. extensive skin haemorrhages, circulatory collapse, and multiple organ failure. She died within 12 hours of admission. GAS were isolated in blood culture. A seven day-old girl died before admission to hospital. GAS were isolated in blood cultures, cerebrospinal fluid and from her nose and throat. An eight year-old, psychomotoric retarded girl developed a severe left-sided pneumonia, empyema and scarlatina. GAS were detected in throat culture. She responded poorly to high doses of benzylpenicillin given intravenously. She recovered rapidly after thoracotomy and decortication of her left lung. Finally, we describe the case of an 11 year-old boy with rheumatic fever without cardiac involvement. The reported cases underline the need for careful diagnosis and penicillin treatment in cases of GAS-infections.


Subject(s)
Streptococcal Infections/diagnosis , Adult , Cellulitis/microbiology , Child , Erysipelas/microbiology , Female , Glomerulonephritis/microbiology , Humans , Impetigo/microbiology , Infant, Newborn , Lymphadenitis/microbiology , Male , Otitis Media/microbiology , Penicillin G/therapeutic use , Pharyngitis/microbiology , Sepsis/microbiology , Streptococcal Infections/drug therapy , Streptococcal Infections/immunology , Streptococcus pyogenes/classification , Tonsillitis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...